Related Experiment Video
Updated: Dec 26, 2025

Probing RNA Structure with Dimethyl Sulfate Mutational Profiling with Sequencing In Vitro and in Cells
Published on: December 9, 2022
The potential chemical structure of anti-SARS-CoV-2 RNA-dependent RNA polymerase
Jrhau Lung1, Yu-Shih Lin2, Yao-Hsu Yang3,4,5
1Department of Research and Development, Chiayi Chang Gung Memorial Hospital, Chiayi Branch, Putzu, Taiwan.
Abstract:
An outbreak of coronavirus disease 2019 (COVID-19) occurred in Wuhan and it has rapidly spread to almost all parts of the world. For coronaviruses, RNA-dependent RNA polymerase (RdRp) is an important polymerase that catalyzes the replication of RNA from RNA template and is an attractive therapeutic target. In this study, we screened these chemical structures from traditional Chinese medicinal compounds proven to show antiviral activity in severe acute respiratory syndrome coronavirus (SARS-CoV) and the similar chemical structures through a molecular docking study to target RdRp of SARS-CoV-2, SARS-CoV, and Middle East respiratory syndrome coronavirus (MERS-CoV). We found that theaflavin has a lower idock score in the catalytic pocket of RdRp in SARS-CoV-2 (-9.11 kcal/mol), SARS-CoV (-8.03 kcal/mol), and MERS-CoV (-8.26 kcal/mol) from idock. To confirm the result, we discovered that theaflavin has lower binding energy of -8.8 kcal/mol when it docks in the catalytic pocket of SARS-CoV-2 RdRp by using the Blind Docking server. Regarding contact modes, hydrophobic interactions contribute significantly in binding and additional hydrogen bonds were found between theaflavin and RdRp. Moreover, one π-cation interaction was formed between theaflavin and Arg553 from the Blind Docking server. Our results suggest that theaflavin could be a potential SARS-CoV-2 RdRp inhibitor for further study.
Insights
Theaflavin, a compound from traditional Chinese medicine, shows potential as an inhibitor for the RNA-dependent RNA polymerase (RdRp) of SARS-CoV-2, SARS-CoV, and MERS-CoV. Molecular docking studies indicate strong binding interactions, suggesting therapeutic possibilities for COVID-19 treatment.
Area of Science:
- Virology
- Medicinal Chemistry
- Computational Biology
Background:
- The COVID-19 pandemic, caused by SARS-CoV-2, necessitates the development of effective antiviral therapies.
- RNA-dependent RNA polymerase (RdRp) is a crucial enzyme for coronavirus replication and a significant therapeutic target.
Purpose of the Study:
- To identify potential inhibitors of SARS-CoV-2 RdRp from traditional Chinese medicinal compounds.
- To evaluate the binding affinity of theaflavin to the RdRp of SARS-CoV-2, SARS-CoV, and MERS-CoV using molecular docking.
Main Methods:
- Molecular docking studies were performed using iDOCK and a Blind Docking server.
- Screening involved traditional Chinese medicinal compounds with known antiviral activity against SARS-CoV.
- Analysis of binding interactions, including hydrophobic interactions, hydrogen bonds, and π-cation interactions.
Main Results:
- Theaflavin exhibited favorable binding scores and energies when docked into the catalytic pocket of SARS-CoV-2 RdRp (-9.11 kcal/mol with iDOCK, -8.8 kcal/mol with Blind Docking).
- Theaflavin also showed significant binding to the RdRp of SARS-CoV (-8.03 kcal/mol) and MERS-CoV (-8.26 kcal/mol).
- Key interactions included hydrophobic forces, hydrogen bonds, and a π-cation interaction with Arg553.
Conclusions:
- Theaflavin demonstrates potential as a SARS-CoV-2 RdRp inhibitor.
- Its binding efficacy across different coronaviruses warrants further investigation for antiviral drug development.
More Related Videos
09:08Generation and Assembly of Virus-Specific Nucleocapsids of the Respiratory Syncytial Virus
Published on: July 27, 2021
09:04Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids
Published on: September 21, 2017
Related Concept Videos
Nucleic Acid Structure
DNA Structure
DNA...
Bacterial RNA Polymerase
In most genes, the transcription site is a single base present upstream of the coding sequence. Though RNAP is a catalytically efficient enzyme, it does not recognize...
Bacterial RNA Polymerase
RNA Structure
Different Types of RNA Have the Same Basic Structure
There are three main types of ribonucleic acid (RNA) involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). All three...
RNA Structure
The basic structure of RNA consists of a five-carbon sugar and one of four nitrogenous bases. Although most RNA is single-stranded, it can form complex secondary and tertiary structures. Such structures play essential roles in the regulation of transcription and translation.
Different Types of RNA Have the Same Basic Structure
There are three main types of ribonucleic acid (RNA): messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). All three RNA types consist of a...
Eukaryotic RNA Polymerases
All three eukaryotic RNAPs require specific transcription factors, of which the...